Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GOLD THIOMALATE for Mobility decreased: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where GOLD THIOMALATE was used for Mobility decreased.

Most Reported Side Effects for GOLD THIOMALATE

Side Effect Reports % Deaths Hosp.
Drug ineffective 2,904 65.0% 675 1,471
Rheumatoid arthritis 2,472 55.3% 694 1,270
Off label use 1,909 42.7% 904 1,394
Joint swelling 1,804 40.4% 702 1,122
Drug hypersensitivity 1,778 39.8% 568 1,256
Drug intolerance 1,681 37.6% 658 1,181
Pain 1,663 37.2% 736 1,197
Contraindicated product administered 1,583 35.4% 607 1,034
Treatment failure 1,530 34.2% 454 824
Arthralgia 1,481 33.1% 629 982
Rash 1,417 31.7% 632 1,082
C-reactive protein increased 1,402 31.4% 675 1,071
Arthropathy 1,366 30.6% 655 1,051
Condition aggravated 1,363 30.5% 544 863
Peripheral swelling 1,269 28.4% 531 853

Other Indications for GOLD THIOMALATE

Product used for unknown indication (2,531) Rheumatoid arthritis (2,334) Systemic lupus erythematosus (171) Foetal exposure during pregnancy (70) Rash (44) Exposure during pregnancy (29) Blau syndrome (22) Joint stiffness (7) Pain (7)

Other Drugs Used for Mobility decreased

DALFAMPRIDINE (74) LEFLUNOMIDE (48) NAPROXEN (48) DICLOFENAC (46) GOLD (46) ADALIMUMAB (45) IBUPROFEN (45) ETANERCEPT (43) ASPIRIN (41) METHOTREXATE (39)

Related Pages

GOLD THIOMALATE Full Profile All Mobility decreased Drugs GOLD THIOMALATE Demographics GOLD THIOMALATE Timeline